Bloodstream Infections in Patients with Solid Tumors: Associated Factors, Microbial Spectrum and Outcome

[1]  L. Thuler,et al.  Epidemiology of bloodstream infections at a cancer center. , 2000, Sao Paulo medical journal = Revista paulista de medicina.

[2]  G. Peters,et al.  New Aspects in the Molecular Basis of Polymer-Associated Infections due to Staphylococci , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[3]  D. McClish,et al.  Nosocomial bloodstream infections in United States hospitals: a three-year analysis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Viscoli,et al.  Planned progressive antimicrobial therapy in neutropenic patients , 1998, British journal of haematology.

[5]  C. Viscoli,et al.  The Evolution of the Empirical Management of Fever and Neutropenia in Cancer Patients Criteria for Selecting an Antibiotic Regimen Local Epidemiology General Epidemiology Regimen Used Combination Therapy Inclusion of Gram-positive Cover in Empirical Therapy Methodological Issues Study Design in Expl , 2022 .

[6]  J. Šufliarský,et al.  Predictors of mortality in bacteremic cancer patients: retrospective analysis of 64 deaths occurring among 262 bacteremic episodes , 1998, Supportive Care in Cancer.

[7]  E. González-Barca,et al.  Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution , 1996, European Journal of Clinical Microbiology and Infectious Diseases.

[8]  R. Wenzel,et al.  Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  S. Schimpff,et al.  Infections in cancer patients: some controversial issues , 1994, Supportive Care in Cancer.

[10]  A. Brown,et al.  The changing epidemiology of infections at cancer hospitals. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  K. Singh,et al.  Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[13]  S. Handwerger,et al.  Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  J. E. Turner,et al.  BacT/Alert: an automated colorimetric microbial detection system , 1990, Journal of clinical microbiology.

[15]  B. Yangco,et al.  CDC definitions for nosocomial infections. , 1989, American journal of infection control.

[16]  J M Hughes,et al.  CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.

[17]  T. Calandra,et al.  Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. , 1987, The New England journal of medicine.

[18]  D. Armstrong,et al.  Bacteremia and fungemia in patients with neoplastic disease. , 1987, The American journal of medicine.

[19]  W. P. Reed,et al.  Adherent microorganisms on lumenal surfaces of long-term intravenous catheters. Importance of Staphylococcus epidermidis in patients with cancer. , 1986, Archives of internal medicine.

[20]  L. Elting,et al.  Polymicrobial Septicemia in the Cancer Patient , 1986, Medicine.

[21]  W. R. Mccabe,et al.  Gram-negative bacteremia: IV. Re-evaluation of clinical features and treatment in 612 patients , 1980 .

[22]  M. Kaplan,et al.  Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases. , 1977, The American journal of medicine.

[23]  J. Lewis,et al.  Gram-negative bacteremia. , 1969, The Johns Hopkins medical journal.

[24]  Y. S. Sathe,et al.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. , 1966, Annals of internal medicine.

[25]  G. Jackson,et al.  Gram-Negative Bacteremia: I. Etiology and Ecology , 1962 .

[26]  C. Lasset,et al.  Prospective multicentric study of the etiology of 1051 bacteremic episodes in 782 cancer patients , 2004, Supportive Care in Cancer.

[27]  Daniel J Sexton,et al.  Health CareAssociated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections , 2002, Annals of Internal Medicine.

[28]  R. Herbrecht,et al.  Prospective study of bacteraemia in cancer patients. Results of a French multicentre study. , 1998, Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.

[29]  T. Calandra,et al.  Gram-positive bacteraemia in granulocytopenic cancer patients. , 1990, European journal of cancer.

[30]  S. Pauluzzi,et al.  Septicaemia due to gram-positive cocci in cancer patients. , 1988, The Journal of antimicrobial chemotherapy.

[31]  M. Tattersall,et al.  Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group. , 1978, The Journal of infectious diseases.